TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.